Hepatitis: all 3,372 studies

Page 3 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.

• Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B InfectionCompletedNCT04980482Phase 2Results posted
• Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)CompletedNCT04903626Phase 3Results posted
• A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B InfectionTerminatedNCT04820686Phase 2Results posted
• TeleHepC Treatment TrialCompletedNCT04798521Not applicableResults posted
• Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatitis (AIH)TerminatedNCT04790916Phase 2Results posted
• A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT04781647Phase 2Results posted
• First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBVCompletedNCT04778904Phase 1/2Results posted
• Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT04749368Phase 2Results posted
• Hepatitis C Pharmacy-based Strategy for InjectorsCompletedNCT04698629Results posted
• Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)CompletedNCT04676724Phase 2Results posted
• A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCompletedNCT04667104Phase 2Results posted
• Supporting Treatment Outcomes Among PWIDCompletedNCT04652804Not applicableResults posted
• A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus InfectionCompletedNCT04585789Phase 2Results posted
• Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic DonorsCompletedNCT04575896Phase 4Results posted
• A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy AdultsCompletedNCT04531098Phase 3Results posted
• QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/PibrentasvirTerminatedNCT04515797Phase 4Results posted
• Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland ChinaCompletedNCT04507269Phase 2Results posted
• A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)CompletedNCT04490499Phase 3Results posted
• Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)TerminatedNCT04465916Phase 2Results posted
• HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine NonrespondersCompletedNCT04456504Phase 4Results posted
• A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase InhibitorsTerminatedNCT04454567Phase 2Results posted
• A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)CompletedNCT04449029Phase 2Results posted
• Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)CompletedNCT04427202Not applicableResults posted
• Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus InfectionCompletedNCT04423393Phase 1Results posted
• Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus InfectionCompletedNCT04412863Phase 2Results posted
• A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT04398134Phase 2Results posted
• Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/VelpatasvirCompletedNCT04382404Phase 1Results posted
• Prevalence of HBV in Pregnant Women Attending Antenatal Care in TanzaniaCompletedNCT04325542Not applicableResults posted
• The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B ScreeningCompletedNCT04240678Not applicableResults posted
• Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT04211909Phase 3Results posted
• Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®CompletedNCT04209400Phase 3Results posted
• Hepatitis C-Video vs. Brochure Education DeliveryCompletedNCT04204447Not applicableResults posted
• A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus InfectionCompletedNCT04129554Phase 2Results posted
• Association of Hepatitis C Virus With Breast CancerCompletedNCT04090164Results posted
• Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic HepatitisCompletedNCT04072822Phase 2Results posted
• Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus InfectionCompletedNCT04042740Phase 2Results posted
• A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus InfectionCompletedNCT03982186Phase 2Results posted
• Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis BCompletedNCT03905655Phase 2Results posted
• HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS FunctionCompletedNCT03902366Results posted
• eHealth Partnered Evaluation Initiative - Evaluation of the Initial Deployment of VA's Annie Texting SystemCompletedNCT03898349Not applicableResults posted
• Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid TumorsTerminatedNCT03887702Phase 3Results posted
• Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)CompletedNCT03852433Phase 2Results posted
• Alcoholic Hepatitis Network Observational StudyCompletedNCT03850899Results posted
• Vitamin C Infusion for TReatment in Sepsis and Alcoholic HepatitisCompletedNCT03829683Phase 2Results posted
• Safety Study of Hepatitis E Vaccine (HEV239)CompletedNCT03827395Phase 1Results posted
• Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C EradicationCompletedNCT03823911Phase 4Results posted
• Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) InfectionTerminatedNCT03820258Phase 2Results posted
• Utilization of Hepatitis C Positive Kidneys in Negative RecipientsCompletedNCT03801707Phase 2/3Results posted
• B/F/TAF Switch Study for HIV-HBV CoinfectionCompletedNCT03797014Phase 4Results posted
• Multi-center Study to Transplant Hepatitis-C Infected KidneysCompletedNCT03781726Phase 4Results posted
• A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B PatientsTerminatedNCT03780543Phase 2Results posted
• IL-1 Signal Inhibition in Alcoholic HepatitisCompletedNCT03775109Phase 2Results posted
• A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT03762681Phase 1Results posted
• Transplanting Hepatitis C Lungs Into Negative Lung RecipientsCompletedNCT03724149Phase 1/2Results posted
• HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)CompletedNCT03685708Phase 2Results posted
• Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis BCompletedNCT03672188Phase 1/2Results posted
• Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCVCompletedNCT03652675Not applicableResults posted
• Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive DonorsCompletedNCT03627299Phase 4Results posted
• Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung TransplantTerminatedNCT03625687Phase 4Results posted
• Twinrix Pregnancy RegistryCompletedNCT03619590Results posted
• Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on TreatmentCompletedNCT03615066Phase 2Results posted
• Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda InterferonCompletedNCT03600714Phase 2Results posted
• A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)CompletedNCT03577171Phase 2Results posted
• A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B InfectionCompletedNCT03576066Phase 2Results posted
• Arresting Vertical Transmission of Hepatitis B VirusCompletedNCT03567382Phase 4Results posted
• A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis DCompletedNCT03546621Phase 2Results posted
• Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016)CompletedNCT03537274Phase 2/3Results posted
• Mild Hypothermia and Acute Kidney Injury in Liver TransplantationTerminatedNCT03534141Not applicableResults posted
• A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With MavyretCompletedNCT03523871Phase 2Results posted
• Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)CompletedNCT03501550Phase 2Results posted
• Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis BCompletedNCT03491553Phase 2Results posted
• Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) InfectionTerminatedNCT03487848Phase 2Results posted
• Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]CompletedNCT03480932Phase 2/3Results posted
• Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)CompletedNCT03471624Phase 4Results posted
• Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic HepatitisTerminatedNCT03452540Phase 2Results posted
• Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)TerminatedNCT03434353Phase 2Results posted
• A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic HepatitisCompletedNCT03432260Phase 2Results posted
• Helping Empower Liver and Kidney PatientsCompletedNCT03426787Not applicableResults posted
• An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis CCompletedNCT03423641Results posted
• EBR/GZR for HCV-1b Patients Receiving HemodialysisCompletedNCT03420300Phase 4Results posted
• Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional VaccinesCompletedNCT03410953Phase 4Results posted
• Lot-to-lot Consistency of Sci-B-Vac™ in AdultsCompletedNCT03408730Phase 3Results posted
• Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in AdultsCompletedNCT03393754Phase 3Results posted
• Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis CCompletedNCT03365635Phase 4Results posted
• Computer-based Intervention for Alcohol-using HIV/HCV+ WomenCompletedNCT03362476Not applicableResults posted
• An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus InfectionCompletedNCT03361956Phase 2Results posted
• Immunogenicity of Hepatitis B Vaccination in HIV-infected AdultsCompletedNCT03316807Phase 4Results posted
• Ledipasvir/Sofosbuvir for Hepatitis B Virus InfectionCompletedNCT03312023Phase 2Results posted
• A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis BCompletedNCT03258710Phase 4Results posted
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03235349Phase 3Results posted
• A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction ClinicCompletedNCT03235154Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03222583Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 InfectionCompletedNCT03219216Phase 3Results posted
• Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)CompletedNCT03214679Not applicableResults posted
• Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1CompletedNCT03212521Phase 3Results posted
• DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart TransplantTerminatedNCT03208244Phase 4Results posted
• Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)CompletedNCT03180619Phase 2Results posted
• Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors (HCV)CompletedNCT03146741Phase 1/2Results posted
• Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDsCompletedNCT03127358Not applicableResults posted
• Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-InfectionCompletedNCT03119025Phase 1/2Results posted

← Hepatitis overview